|
Volumn 277, Issue 37, 2002, Pages 33648-33653
|
Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IκBα degradation without affecting phosphorylation or ubiquitination
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ENZYME INHIBITION;
PROTEINS;
SIGNALING;
TUMORS;
VIRUSES;
PHOSPHORYLATION;
DEGRADATION;
CATHEPSIN G;
ELASTASE;
I KAPPA B ALPHA;
I KAPPA B BETA;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
IMMUNOGLOBULIN G;
INTERLEUKIN 1 RECEPTOR;
LIPOPOLYSACCHARIDE;
REGULATOR PROTEIN;
SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;
TUMOR NECROSIS FACTOR ALPHA;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
ENZYME ACTIVITY;
EPITHELIUM CELL;
HUMAN;
HUMAN CELL;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOPRECIPITATION;
LUNG INJURY;
MACROPHAGE;
NEUTROPHIL;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN PHOSPHORYLATION;
RAT;
CYSTEINE ENDOPEPTIDASES;
DNA-BINDING PROTEINS;
HUMANS;
I-KAPPA B PROTEINS;
INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES;
LIPOPOLYSACCHARIDES;
MULTIENZYME COMPLEXES;
PHOSPHORYLATION;
PROTEASOME ENDOPEPTIDASE COMPLEX;
PROTEIN KINASES;
PROTEINASE INHIBITORY PROTEINS, SECRETORY;
PROTEINS;
SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR;
U937 CELLS;
UBIQUITIN;
ANIMALIA;
HUMAN IMMUNODEFICIENCY VIRUS;
|
EID: 0037072766
PISSN: 00219258
EISSN: None
Source Type: Journal
DOI: 10.1074/jbc.M203710200 Document Type: Article |
Times cited : (136)
|
References (23)
|